BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3114012)

  • 1. Estrone-3-glucuronide chemiluminescence immunoassay: an alternative method for monitoring induction of ovulation with human menopausal gonadotropin in an in vitro fertilization program.
    Lessing JB; Peyser MR; Gilad S; Amit A; Kogosowski A; Yovel I; Barak Y; David MP
    Fertil Steril; 1987 Sep; 48(3):450-3. PubMed ID: 3114012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrone 3-glucuronide chemiluminescence immunoassay (LIA) and 17beta estradiol radioimmunoassay (RIA) in the monitoring of superovulation for in vitro fertilization (IVF): correlation with follicular parameters and oocyte maturity.
    Rapi S; Fuzzi B; Mannelli M; Pratesi S; Criscuoli L; Pellegrini S; Messeri G
    Acta Eur Fertil; 1992; 23(2):63-8. PubMed ID: 1338258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excretion of total estrogens and estrone-3-glucuronide during treatment with human menopausal gonadotropins.
    Frenkel Y; Eshkol A; Tikotzky D; Mashiach S; Lunenfeld B
    Eur J Obstet Gynecol Reprod Biol; 1985 Jul; 20(1):27-33. PubMed ID: 3928414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between plasma estradiol and estrone-3-glucuronide in urine during the monitoring of ovarian induction therapy.
    Catalan R; Castellanos JM; Palomino T; Senti M; Antolin M; Galard RM
    Int J Fertil; 1989; 34(4):271-5. PubMed ID: 2570765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of glucuronometabolites of 17 beta-estradiol and progesterone in early morning urine samples: a promising new method for the evaluation of hormonal responses of Buserelin-hMG treatment in an IVF program.
    Pellegrini S; Rapi S; Coccia E; Pieri A; Mannelli M; Buzzoni P
    Acta Eur Fertil; 1989; 20(4):203-9. PubMed ID: 2519572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luteinizing response to human chorionic gonadotropin does not predict outcome in gonadotropin releasing hormone agonist-suppressed/human menopausal gonadotropin-stimulated in vitro fertilization (IVF) cycles.
    Penzias AS; Shamma FN; Gutmann JN; Seifer DB; DeCherney AH; Lavy G
    J Assist Reprod Genet; 1992 Jun; 9(3):244-7. PubMed ID: 1525454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: phase I, 1981.
    Garcia JE; Jones GS; Acosta AA; Wright G
    Fertil Steril; 1983 Feb; 39(2):167-73. PubMed ID: 6217993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delaying human chorionic gonadotropin administration in human menopausal gonadotropin-induced cycles decreases successful in vitro fertilization of human oocytes.
    Laufer N; DeCherney AH; Tarlatzis BC; Zuckerman AL; Polan ML; Dlugi AM; Graebe R; Barnea ER; Naftolin F
    Fertil Steril; 1984 Aug; 42(2):198-203. PubMed ID: 6430722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovulation prediction: changes in the concentrations of urinary estrone-3-glucuronide, estradiol-17 beta-glucuronide and estriol-16 alpha-glucuronide during conceptional cycles.
    Branch CM; Collins PO; Collins WP
    J Steroid Biochem; 1982 Feb; 16(2):345-7. PubMed ID: 7078170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone excretion during early pregnancy following spontaneous and clomiphene citrate-induced ovulation.
    Strigini F; Collins WP; Whitehead MI; Benedetto Melis G; Fioretti P; Campbell S
    Fertil Steril; 1986 Aug; 46(2):209-14. PubMed ID: 3732527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer.
    Huang JC; Jackson KV; Hornstein MD; Ginsburg ES
    J Assist Reprod Genet; 1996 Sep; 13(8):617-24. PubMed ID: 8897120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma hormones in human gonadotropin induced ovulation.
    Wu CH
    Obstet Gynecol; 1977 Mar; 49(3):308-13. PubMed ID: 840459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization.
    Garcia JE; Padilla SL; Bayati J; Baramki TA
    Fertil Steril; 1990 Feb; 53(2):302-5. PubMed ID: 2105247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: phase II, 1981.
    Garcia JE; Jones GS; Acosta AA; Wright G
    Fertil Steril; 1983 Feb; 39(2):174-9. PubMed ID: 6401635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between urinary estrone conjugates as measured by enzyme immunoassay and serum estradiol in women receiving gonadotropins for in vitro fertilization.
    Alper MM; Halvorson L; Lasley B; Mortola J
    J Assist Reprod Genet; 1994 Sep; 11(8):405-8. PubMed ID: 7606153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of ovulation induction.
    Wu CH
    Fertil Steril; 1978 Dec; 30(6):617-30. PubMed ID: 729822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of rapid and simultaneous measurement of sex steroid hormones to the monitoring of gonadotropin therapy.
    Hayata K; Hayashi N; Sekiba K
    Acta Med Okayama; 1985 Jun; 39(3):161-70. PubMed ID: 3927661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between preovulatory serum 17 beta-estradiol pattern and conception in human menopausal gonadotropin-human chorionic gonadotropin stimulation.
    Laufer N; DeCherney AH; Tarlatzis BC; Naftolin F
    Fertil Steril; 1986 Jul; 46(1):73-6. PubMed ID: 3087791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of growth hormone and gonadotropins in achieving conception in "clonidine-negative" patients with unexplained infertility.
    Blumenfeld Z; Amit T; Barkey RJ; Lunenfeld B; Brandes JM
    Ann N Y Acad Sci; 1991; 626():250-65. PubMed ID: 1905509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.